LVAD Occlusion Condition Monitoring Using Boost Classification Trees by Reuter, Steven Paul
Rochester Institute of Technology 
RIT Scholar Works 
Theses 
10-2019 
LVAD Occlusion Condition Monitoring Using Boost Classification 
Trees 
Steven Paul Reuter 
spr5916@rit.edu 
Follow this and additional works at: https://scholarworks.rit.edu/theses 
Recommended Citation 
Reuter, Steven Paul, "LVAD Occlusion Condition Monitoring Using Boost Classification Trees" (2019). 
Thesis. Rochester Institute of Technology. Accessed from 
This Thesis is brought to you for free and open access by RIT Scholar Works. It has been accepted for inclusion in 
Theses by an authorized administrator of RIT Scholar Works. For more information, please contact 
ritscholarworks@rit.edu. 




Thesis submitted to the Department of Mechanical Engineering
in partial fulfillment of the requirements for the degree of
Masters of Science in Mechanical Engineering
at the
ROCHESTER INSTITUTE OF TECHNOLOGY
Kate Gleason College of Engineering
October 2019
Author . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Department of Mechanical Engineering
October 16, 2019




Accepted by . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dr. Steven Day
Department Head-Biomedical Engineering, Associate Professor
Defense Committee on Graduate Thesis
Accepted by . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dr. Mark Kempski
Professor
Defense Committee on Graduate Thesis
2




Submitted to the Department of Mechanical Engineering
on October 16, 2019, in partial fulfillment of the
requirements for the degree of
Masters of Science in Mechanical Engineering
Abstract
Cardiac related diseases are a serious health risk for adults. Consequently, therapies
exist to treat these aliments such as heart transplant and medication. Heart trans-
plant remains the gold standard for treating severe heart failure, however left ventric-
ular assistive devices, a cardiac blood pump, are become a viable long term treatment.
Unfortunately, with the benefits of these devices come risks of clot formation. These
occlusions can cause strokes, further cardiac damage, or even death. Therefore, it is
critical that these occlusions be detected as early as possible. This work presents an
expanded method to non-invasively monitor the condition of a Thoratec HeartMate
II ventricular assist device through the application of a boosted classification tree. In
addition, both inflow and outflow blockages measured at aorta and pump locations
were experimentally tested on a cardiac phantom. The proposed method presents a
potential outpatient diagnostic method that may assist experienced cardiologists in
their treatment of LVAD patients.
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The following chapter provides background information regarding ventricular assist
devices and cardiac diagnostics. In addition, past work in both fields will be presented
along with the proposed methods of this work.
1.1 Background
1.1.1 Circulatory System
The human body is comprised of a multitude of specialized organs and cells. A net-
work of capillaries, veins, and arteries connect these organs and transport molecules
between them is known as the circulatory system. These vessels are responsible for
bringing oxygen rich blood to the body as well as removing waste produced by cells.
In addition, the circulatory system delivers white blood cells to infected areas of the
body. At the center of this network of nearly 100,000 miles of blood vessels, is the
heart [43]. This unique organ is shown in Fig. 1-1.
In general, the heart’s main function is to create a pressure differential in the
circulatory circuit to induce blood flow. The consequent blood flow is the mechanism
in which molecules are transported to the various systems within the body. The heart
is comprised of three main components; the atria, ventricles, and valves. All three
work together to pump blood through out the circulatory system in what is known
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Figure 1-1: Heart Diagram [4]
as the cardiac cycle.
The atria and ventricles are responsible for generating the aforementioned pres-
sure differential and moving discrete volumes of blood through the circulatory paths.
They accomplish this by contracting and relaxing to either expel or intake blood. The
primary function of valves is to control the blood flow between corresponding heart
chambers. They either open or close to allow the heart to move blood in the correct
direction. The four main valves, atrial, mitral, pulmonary, and tricuspid are unidi-
rectional so blood can only flow in one direction through the heart. This prevents
back flow and allows for a sufficient pressure differential to be generated.
Cardiac Cycle
Blood moves through the heart simultaneously in two independent circuits, the pul-
monary and systemic. The pulmonary circuit flows between the lungs and heart,
oxygenating depleted blood used up by the body. This circuit is fed by the right
ventricle and re-enters the heart at the left atrium. Systemic circulation transports
oxygen rich blood to the main circulatory network. Oxygenated blood enters at the
left atrium and is transported through the body by the left ventricle. To complete
these two functions, the heart cycles between a diastole and systole phase [17]. The
diastole phase is the expansive intake phase of the cardiac cycle. When the pressure
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in an atria becomes higher than the ventricle, blood enters the ventricles through the
atrioventricular valves. This pressure differential occurs after the ventricle’s myocytes
have relaxed [17]. Diastolic phases occur in both the right and left sides of the heart.
The systole phase is the contraction phase of the cardiac cycle. The circumferential
myocytes of the ventricle contract, raising the pressure of the blood taken in during
the diastole phase. Increasing the ventricular pressure beyond that of the correspond-
ing vein and or artery results in the expulsion of blood to the pulmonary and systemic
circuits [17]. Similar to diastole, both sides experience a systolic phase.
1.1.2 Heart Disease
In general, heart disease encompasses a variety of conditions in which the heart is
no longer able to effectively or efficiently pump blood to either the pulmonary and
systemic circulatory circuits. For example, cardiomyopathy is a common heart disease
and results in a weakened systolic phase. Consequently, blood builds up in the lungs
and vital organs do not recieve fresh oxygenated blood [50]. This symptom is often
linked with coronary heart disease which results in 1 in 7 deaths in the United States
[2]. LVADs are a direct response to such a prevalence of heart disease and are a
promising addition to previous heart therapies.
1.1.3 Heart Therapies
Although the effects of heart disease are profound, there are medical therapies in
place to help patients recover and imporove thier quality of life. Low risk treatments
include diet, exercise and medication. However, more severe cases of heart disease
may require an orthotopic heart transplant. This procedure carries immense risk
and many patients perish awaiting a suitable donor organ. An alternative to an
orthotopic heart transplant is the use of a ventricular assistive device (VAD). These
devices work in parallel with the heart, providing support to either the pulmonary
or systemic circulatory circuit. Also, VADs have been very successful in treating
patients with heart failure who are not eligible for a heart transplant. Overal, the
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one year LVAD survival rate is 81% [22] while heart transplants are at 81.5 % [27].
VADs can be applied to the right or left side of the heart. Most commonly, they
are used in conjunction with the left ventricle. This aids the heart in providing fresh
oxygenated blood to the systemic circuit. Specifically, a Left Ventricular Assist Device
(LVAD) is used for three main treatment types, bridge to transplant, destination
therapy, and bridge to recovery.
Bridge to Transplant
Donor hearts are not always readily available for transplant. Consequently, patients
often wait years for a suitable donor to become available. LVADs are implanted in
these patients to prolong their life while they wait. The LVAD can function for years,
increasing and maintaining the patient’s quality of life [9].
Destination Therapy
Unfortunately not all patients diagnosed with heart disease are eligible for a heart
transplant. Applicable preexisting conditions include age (>70 years old), an active
smoker, or having been recently diagnosed with cancer [19]. For these individuals, an
LVAD is implanted as a permanent solution for their heart disease.
Bridge to Recovery
LVADs can also be used to treat temporary heart failure. The device’s assistive nature
allows the heart to "rest" and often heal itself under the lighter load. This bridge to
recovery treatment is less common than the previous two in that heart failure is often
irreversible [7].
1.1.4 Continuous Flow LVAD
Continuous flow (CF) LVADs are widely used in the medical field due to their in-
creased longevity and smaller size compared to pulsatory flow devices [24]. In addi-
tion, they use simpler mechanisms than volume-displacement pumps which reduces
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component failure. As of 2017, upwards of 95% of implanted LVADs are CF de-
vices [22]. The first type of CF LVAD implanted in patients generated blood flow
using rotating axial vanes. The pumps showed great promise as an alternative to the
pulsatory mechanisms at the time. However, due to the high RPM and continuous
mechanical nature of the pump vanes, blockages started to be observed in patients
[29].
The Thoratec Heartmate II (HMII) is the specific LVAD to be used in this work.
The HMII is an axial CF LVAD comprised of three main parts. These critical com-
ponents include the inflow graft/cannula, pump housing, and outflow graft/cannula.
The inflow graft is sewn directly into the patients left ventricular wall, allowing the
pump to draw in fresh oxygenated blood from the bottom of the ventricle. This lo-
cation reduces the chances of the pump collapsing the fragile ventricle wall. After
exiting the ventricle, the blood passes through the inflow cannula. Here, it makes a
sharp 90 degree turn into the pump. While entering the pump, blood flows through
three equally spaced fins. These separate and smooth the flow prior to engagement
with the pump vanes. Once inside the pump, blood is shuttled by multiple propeller
vanes rotating on a central axis.
Once blood has exited the pump body, it flows into the outflow cannula towards
the aorta. Similar to the ventricle, a graft is sewn into the aorta to allow blood to
reenter the systemic circuit. Placement of the outflow graft is critical to maintain a
seamless transition of the LVAD and ventricular flow paths.
1.1.5 LVAD Thrombosis
LVAD thrombosis can manifest in multiple areas within the flow path. Specific to the
HMII as seen in Fig. 1-2, the most common areas are the left ventricle, inflow/outlfow
cannula, pump housing and aortic root. Once developed, these thrombus can have
devastating effects on the patient. This work focuses on detecting two specific areas,
the outflow graft and inflow cannula.
Thrombosis commonly presents in two forms independent of LVAD implantation,
arterial and venous [5]. Arterial thrombosis is initiated by an abrupt blockage in the
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Figure 1-2: Thoratec HeartMateII Axial Continuous Flow Pump [25]
blood’s flow path. The sharp onset of turbulent flow activates platelets which adhere
to the blockage. The activated platelets recruit additional platelets flowing by in the
blood stream, causing a chain reaction. Consequently, thrombin is formed as part of
the coagulation cascade and the artery becomes occluded. These brittle thrombus
are typically white in color.
Venous thrombosis forms more slowly in the body and is primarily caused by
stagnation of blood. When blood flow is low, the coagulation cascade can be initiated
unintentionally by exposer to the tissue factor. This generates a softer clot by trapping
red blood cells and slowly creating a fibrin structure [13].
Both arterial and venous thrombi can be formed in the LVAD flow path. Arterial
clots may form in areas of high turbulence such as the pump inlet and aorta outflow
graft. In addition, the pump induces shear stress on the blood which may further
develop an arterial thrombosis. Venous thrombi are typically found in the aortic graft
or in other common points of stagnation. These stagnation points can be "flushed"
out with the help of the pulsating ventricular flow, however in LVAD patients the
ventricle is often too weak to do so. As a result, some modern LVADs change the
pump speed periodically in order to simulate this pulsating flow.
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1.1.6 LVAD Diagnostics
Traditional cardiac diagnostic tools such as auscultation, electrocardiographs (ECG),
angiographs, echocardiograms, and computed tomography (CT) scans have been es-
sential to the medical field thus far. These cutting edge technologies are essential for
detecting clots in patients and are frequently utilized by cardiologists.
Auscultation
One of the earliest and longest enduring methods for cardiac diagnostics is ausculta-
tion. Auscultation refers to listening to sounds from the body, primarily the heart,
lungs, and gastrointestinal system. A stethoscope has primarily been used to amplify
these sounds since its invention in 1819 [11]. A physician uses the stethoscope to
amplify low level sounds such as heart valve events and flowing blood to diagnose
each patient. This skill is finely tuned over many years of training and experience lis-
tening to patients. Typical diagnoses based on auscultation are heart murmurs, valve
stenosis, and irregular heart beats. A successful diagnosis relies on the ability to hear
"heart sounds" emanating from the patient’s circulatory system. In relation to LVAD
diagnosis, auscultation is used to listen for irregular heart or pump sounds. Often, a
physician can detect when the pump is strained due to increased flow resistance or
valve regurgitation. The cardiologist will listen to multiple areas of the chest prior
to making a diagnosis as seen in Fig. 1-3. Specific to LVADs, they typically focus
on the atrial valve or aorta and LVAD. For this reason, measurements were made at
both the aorta and LVAD in this work. By training a classifier for both sites, it is
the aim to make more accurate predictions on LVAD health.
Heart Sounds
As the heart completes the diastolic and systolic phases of the cardiac cycle, audible
signals are generated that resonate through the thoracic cavity. These sounds origi-
nate from turbulent blood flow, valve openings/closings, and muscle vibrations within
the heart and are classified into four distinct sounds [1]. The first sound (S1) occurs
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Figure 1-3: Typical auscultation sites in a healthy patient outlined in green. [30]
during the ventricular systole phase when blood is entering the ventricles and the
mitral and tricuspid valves are closing. As the heart enters the diastolic phase, the
second sound (S2) is generated. Specifically, blood expulsion and the closing of the
aortic and pulmonary valves create the S2 sound. A third (S3) and fourth (S4) sound
are present but are not as prominent as S1 & S2. S3 occurs early in the diastolic
phase as the ventricles rapidly fill with blood from the atria. In healthy adults this
sounds is not always present, but can arise in patients suffering from heart failure. S4
happens in the late diastole and is not audible in a healthy patient. S4 can be heard
if there is a rapid expansion of a stiff ventricle as the atria reach the end of their
contraction. Below is a sample stethoscope and ECG measurement taken during this
work. The equipment used will be outlined in a later section, however it allows for
both measurements to be taken symultaneously. Therefore, Fig. 1-4 clearly shows
the S1 and S2 sounds as well as the ECG R-peak.
Electrocardiography
The electrocardiogram (ECG) is a profound cardiac diagnostic tool. It works by
measuring the electrical potential across points of the body to record heart activity.
This electrical potential orgiginates from cardiac muscles activating during each cycle
and is present on the ECG baseline recording [35]. A sample ECG wave can be seen
in Fig. 1-5.
As a diagnostic tool, cardiologists rely on a patients ECG to detect conditions such
as arrhythmia or structural flaws. ECG alone has been proven to be exceptionally
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Figure 1-4: Personal heart sounds and ECG measurements recorded during stetho-
scope validation
Figure 1-5: ECG measurement of cardiac cycle [15]
useful, but coupled with additional methods cardiologists have an even better under-
standing of a patients heart. For example, a physician can see when a contraction
was signaled on the ECG then listen for the hearts reaction using a stethoscope. In
relation to LVAD diagnostics, a cardiologist often uses the ECG results to first detect
a change in the patients health due to a blockage.
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Figure 1-6: Angiography view of patients heart [10]
Angiography
A more invasive procedure for cardiac diagnostics is the angiography. In this method,
a contrast medium is injected into the patient making the blood visible on an x-ray
as seen in Fig. 1-6. Being able to visualize the blood flow inside an organ allows
physicians to detect occlusions, stenosis, and various forms of heart disease. The
benefits of this method are great but can cause complications. Patients with kidney
disease can have trouble filtering the contrast medium and the catheter to inject
the medium can dislodge plaque deposits and trigger a heart attack or stroke [10].
Another downside to this technique is that metal objects within the body can obstruct
the contrast material on the x-ray image. This makes angiography very difficult to
use when attempting to detect occlusions within an LVAD in that the pump is made
of metal.
Echocardiography
Echocardiography obtains in vivo images of cardiac structure and blood flow using
ultrasound. The ultrasound waves are emitted into the patients chest and their re-
flections back to the instrument produce an image after signal processing. This image
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clearly outlines tissue interfaces of the heart and advanced Doppler instruments can
even measure the velocity of blood cells as shown in Fig. 1-7. Echocardiogram im-
agery can be very useful in non-invasivly detecting abnormal blood flow paths in a
patient.
The recent utilization of the Doppler effect and high frequency echocardiograms
has lead to even more LVAD diagnostic capability. Resulting images show the speed
and direction of blood flow throughout the cardiac system. This allows cardioligists
to track a patients resting numerical blood flow. When their flow changes, it can
be an indication of a blockage. For example, Grinstein et al. [14] recently used a
population of 57 patients in a study to determine a mean blood flow for the HMII
and Heartware pumps. Using patient specific flow rates, they were able to successfully
detect device malfunctions and even prevent a thrombotic event.
Figure 1-7: Doppler Echo
Computed Tomography Scans
A computed tomography (CT) scan can be very beneficial when diagnosing an LVAD
thrombosis. The scan uses a multitude of contrasted X-ray images stitched together
to give a planar section view of a patient. From the image, one can visualize occlusions
and misaligned LVAD components at any angle. Also, recent advances in contrast
techniques permit cardiologists to view inside both the grafts and outflow cannula.
These new scans allow radiologists to see into the grafts non-invasively and pinpoint a
potential location of thrombosis. Tran et al.[44] have been very successful in detecting
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thrombus in patients using CT scans, discovering four LVAD complications (two
thrombus & two LVAD complications). Fig. 1-8 shows a thrombus developing in
one of the four patients. It was later surgically confirmed and removed.
Figure 1-8: CT images showing outflow graft thrombus detected in patient. [44]
Overall, the presented diagnostic tools are critical in allowing highly trained cardi-
ologists to detect thrombi in LVAD patients. They have drastically improved the level
of patient care and the use of LVADs would be risky without them. Although they
are outstanding tools, their use is often limited by cost, availability of trained medical
staff, and access to a hospital. Therefore, this work aims to develop a tool/algorithm
that can aid in diagnosis prior to a hospital visit at a much lower cost.
1.2 Need for Research
Beginning from 1966 when the first LVAD was implanted [20], their side effects and
correlated causes have been studied both academically and clinically. As mentioned
previously, a critical side effect resulting from LVAD implantation are blood clots.
These clots form in the vessels and arteries surrounding the LVAD grafts as well as
within the pump. These occlusions can be extremely dangerous and even fatal to
LVAD patients. Unfortunately, this complication has been increasing in frequency
since a sharp rise in 2011 [42]. Since discovering the prevalence of thrombosis forma-
tion, physicians and scientists have been developing early detection methods. Starling
et al.[42] showed that elevated lactate dehydrogenase (LDH) levels can indicate the
presence of a thrombus. This method was successful in their trial but required routine
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and invasive laboratory blood tests.
Non-invasive techniques of thrombus diagnosis has been a growing field for many
years. Along side traditional cardiac tools mentioned previously, digital signal pro-
cessing of stethoscope recordings are a promising method used by researchers and
physicians alike. This has become accessible to more professionals recently with the
advent of commercial digital stethoscopes such as the Thinklabs One Digital Stetho-
scope (Thinklabs, CO). In addition, the ever evolving microprocessor industry allows
for more efficient analysis of signals and images on smaller hand held devices.
At the core of LVAD diagnostic signal processing are heart sounds. Wood et
al. [48] showed early on that time-frequency techniques are useful in understanding
recorded heart sounds. Their work focused on S1 and its correlation to prosthetic
valve health. The authors used a Short Time Fourier Transform (STFT) to analyze
the heart sound, a suitable choice for a non-stationary signal. Although an LVAD was
not implanted in their patients, the analysis of a foreign cardiovascular object using
time-frequency methods is extremely relevant to LVAD diagnostics. Low pass filtering
is applied in most scenarios when processing digital stethoscope signals. This filter
primarily filters out noise recorded by the stethoscope’s high sensitivity and sampling
rate. Noise comes from the ambient environment as well as the thoracic cavity. Work
published by Okamoto et al. [34] shows the importance of low pass filtering and
optimization routines resulting in the ideal cut off frequency. The researchers utilized
a stationary transform known as the Fast Fourier Transform (FFT) after filtering the
signals.
Assuming a stationary or non-stationary signal is mixed in the literature. Authors
have been able to achieve agreeable results using both in their respective studies.
However, this is dependent on what region of interest they are classifying. Processing
a single heart sound is best served by a non-stationary assumption. However, when
focusing on a small region a stationary transform can yield favorable results. For ex-
ample, Kaufmann et al. [21] used an FFT spectrogram to diagnose pump thrombosis
in rotary LVAD. The group was interested in clots forming within the pump which
were very prevalent in the results. Using the known motor frequency and number of
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vanes, the authors could deduce what frequencies would increase in amplitude when
a single or multiple vanes developed a clot. Hubbert et al. [16] also used station-
ary techniques to detect LVAD thrombosis. Their work comprehensively tested inlet,
outflow, and internal blockages surrounding a HMII.
Leung et al. [26] proposed using a non-stationary transform (STFT) in classifying
heart sounds. They focused their processing on the diastole and systole phase as
to eliminate valvular effects. This worked well and resulted in a clearer signal as
opposed to the entire heart sound. In addition, the authors outlined their classification
methods for determining if the resulting spectra images indicated a blockage.
Classification remains an intriguing part of LVAD thrombosis detection. The
constantly evolving algorithms and processing techniques surrounding classification
make it an ever adaptable tool. Nirschl et al. [32] showcase a convolution neural
network classifier applied to heart tissue images. This network excels at classifying
images on the pixel scale. This eliminates manual feature generation and incorporates
it into the network itself.
The intention of this thesis work is to expand on the preexisting literature sur-
rounding LVAD thrombosis detection. Following a similar procedure to Pretchl et
al. [? ], novel work will encompass both testing conditions as well as classification
techniques. Unique testing conditions will be created in the form of newly designed
inflow & outflow LVAD occlusions. These occlusions mimic the conditions seen by
actual patients based on cardiologist experience. Classification will be carried out
through a new classifier not yet applied to the simulated heart sounds produced by
the RIT cardiac phantom. The combination of these two additions aim to provide a
robust addition to the LVAD diagnostic literature.
1.3 Proposed Methodology
The overarching purpose of this work is to expand on a non-invasive LVAD diagnostic
technique. This technique involves the use of a digital stethoscope to capture heart
sounds from a LVAD patient or cardiac phantom. The given signals are then post
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processed in such a manor as to produce a set number of features. These features
commonly result from some type of time-frequency transform [49] [33] or can focus on
the time indicies [47]. Either way, these features become the input representation to
a given classifier. Classifiers used for this task vary based on the input, but common
methods include support vector machines (SVM) [47], amplitude threshold values
[49], and spectral peaks [21]. From the classifiers results, the researchers and or
cardiologists hope to detect the presence of an LVAD malfunction or thrombus.
Much of the proposed methods to be used in this work are carried over from the
work of Pretchl et el. However, key changes and improvements made will create a more
robust and representative classifier. The bulk of the transferred work is encompassed
in the data post processing. This includes ensemble averaging and application of the
continuous wavelet transformation (CWT). These topics are to be covered in this
document, however they will not be modified from their original development.
Novel work to be completed during this project shall begin with the data col-
lection software/hardware. Hardware modifications include removing the function
generator from the cardiac phantom control architecture. It’s main task of triggering
the pressure controller relay will now be carried out by the National Instruments data
acquisition module. Software modifications reflect the hardware changes by moving
control and acquisition into a signal user interface. The main LabVEIW program will
allow for collection of all pressure, flow, and acoustic signals while generating user
defined heart rates.
Moving on from the control and data collection, physical modifications are to be
added to the cardiac phantom. A new flow path, occlusions, and chamber are the focus
of the revised phantom. Previously, the flow path did not mimic an aortic blockage,
but rather stenosis in the outflow graft. Utilizing, the existing blockage fixture, a more
representative aortic blockage will be incorporated. This new path requires the design
and manufacturing of revised outflow occlusions. These will mimic the blockages seen
in LVAD patients and utilize additive manufacturing for construction. Printing the
blockages allows for much more complex geometries without extensive manufacturing
time and cost. Inflow blockages will now accompany the outflow, again using printing
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methods to manufacture. These blockages will impede flow at the inlet vanes of the
HMII which mimic conditions found in actual LVAD patients. The final addition to
the cardiac phantom will be a new left ventricle chamber. New valves and enclosure
accompany the chamber, providing a more biologically representative and well sealed
unit.
Utilizing the revised cardiac phantom, new data will be collected for classification.
The various conditions tested are to be outlined in chapter 5, with a focus on blockage
combinations and variations in heart rate. This new data will share the identical
format to previous experiments. Therefore, the ensemble averaging and CWT scripts
can be directly applied. Once the new data is collected and transformed into the
time-frequency domain, classification can begin.
Expanding on the previous classification work, a new method using the entire
spectral image is proposed. Based on the previous work with the spectral images
of Prechtl et al, the most promising algorithm is the classification tree (CT). The
main goal is to detect the presence of a blockage (inlet or outlet), however secondary
classification of thrombus location may be explored if basic fault detection yields
promising results.
The remainder of this work will outline the experimental environment, data col-
lection, processing and classification. Chapter 2 focuses on the in vitro simulator
revisions and an overview of how the heart sounds are generated. Chapter 3 outlines
the signal processing algorithm developed by Prechtl et al. in his previous thesis
work. An overview is provided for completeness and relevance to this work. Moving
onto classification, Chapter 4 touches on the classifier’s training algorithm and how
it applies to the LVAD spectra. Chapter 5 provides the final classifier parameters,
data collected, and experimental results. Finally, Chapter 6 concludes the work with




In the absence of an in vivo testing platform, an in vitro cardiac phantom is used for
seed fault testing of the HMII LVAD. The objective of this chapter is to examine the
cardiac phantom used and how it’s components contribute to generating simulated
heart sounds. The simulator used was graciously provided by Dr. Day and the RIT
Biomedical Engineering department for the duration of the thesis work. In addition,
the revisions outlined below include components created in conjunction with Dr. Karl
Schwarz of the University of Rochester Medical Center (URMC).
2.1 Revised Cardiac Phantom
The original phantom was comprised of an outflow occlusion site and a single acous-
tic measurement location. Although these two elements have been expanded upon,
the underlining function of the phantom has remained the same. The following sec-
tion details this function and how each component works together to simulate heart
sounds.
Heart sounds are the main biological signal captured from the phantom, however a
myriad of additional factors must work together to generate reliable acoustic signals.
The first being the electrical trigger to initiate a ventricular contraction.
In the body, the electrical pulse that causes the ventricles of the heart to contract
emanates from the sinoatrial (SA) node. The SA node is located at the top of the
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Figure 2-1: ECG measurement of cardiac cycle [15]
heart and first triggers the atria to contract. This creates a pressure differential
across the mitral (left) and tricuspid (right) atrial valves, causing them to open. Once
blood has entered the ventricles, the SA electrical impulse has had time to travel to
the atroventricular (AV) node. Here, the signal is slightly delayed in order for the
ventricles to fully fill with blood. After the delay, the pulse is released and both left
and right ventricles contract. Similarly to the artia, the pressure differential between
the ventricles and corresponding vessels lead to the aortic (left) and pulmonary (right)
opening.
In a patient, this electrical signal is captured through an ECG and maintains the
following general form in Fig. 2-1.
The most significant section of the ECG wave relevant to this specific cardiac
phantom is the QRS complex. This peak represents ventricular depolarization (con-
traction) and is often used to determine a patients heart rate. In relation to the
phantom, this peak represents the relay trigger in which the ventricle enclosure shall
be pressurized. The T wave seen in Fig. 2.1 shows ventricle relaxation (repolariza-
tion) and allows the chambers to refill with blood. On the phantom, this period will
represent ventricle enclosure depressurization.
The electrical signal used to control ventricular contraction is generated from the
main LabVIEW control program. This command was ported into the main DAQ pro-
gram for increased repeatably and variable heart rate functionality. In addition, the
new digitally controlled signal has the ability to vary duty cycle as well as frequency.
32
Duty cycle represents the active time occupied by a signal in a given period. For
example, if a periodic signal had a duty cycle of 25%, it would be "active" for 25% of
its given period and "deactivated" for the remaining 75%. On the cardiac phantom,
the duty cycle defines the time in which the ventricle enclosure is pressurized. For
this work, the duty cycle was held at 50% for each sample. However future work may
explore how duty cycle effects the authenticity of the generated heart sounds.
The remaining electrical component (aside from sensors) of the cardiac phantom
is the HMII LVAD and controller. These components were graciously lent to the
project by Karl Schwarz M.D. of URMC. The main control one has over the LVAD is
operating speed (RPM). The controller provided is a patient issued unit and therefore
does not have the ability to modify LVAD speed. However, the speed may be changed
by Dr. Schwarz through a clinical controller. The LVAD speed tested in this work
remained at 9200 RPM.
Mechanically, the cardiac phantom best represents the left half of the heart. This
includes the left atrium, mitral valve, left ventricle, aortic valve, aorta, and sys-
temic circulatory network. Their representations are largely functional as opposed to
anatomically correct. However, their function is the key element in the scope of this
work. The entire system can be seen below in Fig. 2-2 and Fig. 2-3 however more
detailed pictures are provided in the respective sections.
The left atrium is represented by a column of water vented to the ambient atmo-
sphere as seen in Fig. 2-4. Given that the model is only comprised of the left heart,
the sole requirement for this reservoir is the ability to open the mitral valve upon
request from the ventricle. This is accomplished by stationing the reservoir above the
ventricle plane. Therefore when the ventricle is depressurized, its internal pressure
is less than that of the atrium reservoir. This pressure differential causes the mitral
valve to open, refilling the ventricle with water.
The aforementioned mitral valve is one of two present in the cardiac phantom;
the other being the aortic. Their main purpose is to act as a single directional check
valves in the cardiac loop. Specifically, the mitral valve permits a single flow path
from the atrium into the ventricle. Meanwhile, the aortic valve permits flow from
33
Figure 2-2: Original Cardiac phantom
Figure 2-3: Revised Cardiac phantom
the ventricle into the aorta. These valves are critical to the simulator as well as
the biological cardiac cycle. Therefore, it is imperative that the cardiac phantom
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Figure 2-4: Atrium and Systemic Circuit Representations
replicate their function as close as possible. Fig. 2-5 clearly shows the position and
unidirectional flow path of the mitral and aortic valves.
Figure 2-5: Unidirectional ventricle flow path
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The mechanism used by biological valves is a simple one in theory. The valve
is comprised of an outlining fibrous ring and multiple cusps (mitral=2, aortic=3) of
tissue which form the main valve body. These cusps are oriented in such a direction to
allow minimal flow resistance in a single direction. In the other direction, a pressure
differential causes the valve to close. This seal is reinforced by tendinous cords that
apply tension to the valve, preventing the valve from folding in on itself.
The single flow path created by the valve is the main reason that the heart is able
to "pump" blood. If it were not for the checking of these valves, blood would never
be expelled from the heart to the pulmonary or systemic circuits. Therefore, similar
valves were installed in the cardiac phantom. Although healthy valves are used in
the work, the simulator can accept valves of many conditions. In the future, various
faulted valves may be tested with or without the LVAD present.
2.1.1 Valve Design
The previous valves used in the phantom were both bileaflet valves and faithfully
served their purpose of providing unidirectional ventricular flow. However, with the
new ventricle chamber being installed, they were no longer initially compatible. This
lead to the development of new valves. These new valves needed to maintain an iden-
tical function to their counterparts, but also interface with the new ventricle chamber.
Also, the valves needed to be modular in anticipation of further valve studies using
the cardiac phantom. These engineering requirements lead to the implementation of a
custom molded silicone trileaflet valve. This type of valve would 1) satisfy the overall
goal of unidirectional flow 2) mimic the aortic valve structure 3) allow for future echo
measurements of the valve 4) interface with the new ventricle chamber.
A partner on the project, Dr. Michael Richards kindly supplied the team with
a mold model for a trileaflet valve. The mold design consisted of three parts and
could be made in a commercially available 3D-printer. In order to be used in the
cardiac phantom, the mold was revised to produce a smaller diameter and shorter
valve. These dimensions were driven by the ventricle chamber and resulted in minimal
modifications to the chamber itself. The 3D model of the valve and corresponding
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Figure 2-6: Valve mold components and final valve model.
valve is shown below in Fig. 2-6.
To further replicate the compliant nature of physical trileaflet valves, the phantom
valves were molded out of silicon. Silicone would also provide an excellent seal in the
presence of back pressure in the chamber. Finally, the silicone could be easily modified
during or after the molding process to produce future revisions of valves. For example,
a hole could be punched in the valve to simulate regurgitation. The silicon chosen
was Dragon SkinTM 10 medium by Smooth-On. This product was selected due to its
elasticity and durability. Once cured, the small opening/closing deformations would
not permanently deform the material. Meanwhile, the silicone was elastic enough to
open a significantly large passage for ventricular flow.
Manufacturing of the valves began with printing molds. From an exported steri-
olithography file (STL), the three mold sections were created with a Markforge Onyx
OneTM. This printer yielded a high resolution carbon reinforced mold capable of
producing multiple valves. Once the mold was complete, initial test valves were pro-
duced. After a sufficient number of trails, a repeatable molding process was created.
This process was repeated for the ventricle chamber as well.
1. Apply silicone mold release to internal surface of mold.
2. Secure side mold sections together using tape or elastic bands.
3. Thoroughly mix equal parts compound A and B for 5 minutes.
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4. Place mixing container into vacuum chamber for 7 minutes.
 Allow for complete degassing
5. Remove mixture and poor into mold cavity
 Fill mold roughly 80% with mixture
6. Press top mold section into place, displacing silicone mixture.
7. Fully seat mold top onto side sections and maintain firm pressure.
8. Place a sufficient weight on top of the mold to maintain pressure and ensure
the top section does not lift off.
9. Allow for 5 hours of curing time before removing the completed silicone valve.
10. Carefully cut the silicone separating each cusp to create the valve opening.
11. Trim off accesses silicone from the molding process and the valve is complete.
When initially installed into the ventricle chamber, the valves performed as ex-
pected. Their flexible cusps opened enough to allow sufficient flow into the ventricle
while quickly closing down in the presence of back pressure. However, once the LVAD
began providing increased aortic pressure (𝑃𝑎 > 60𝑚𝑚𝐻𝑔) a major issue arose with
the valves. The relatively flexible material (10A Shore Hardness) initially chosen
was not strong enough to hold the aortic pressure, causing the cusps to invert back
into the ventricle as shown in Fig. 2-7. To avoid these inversion events, the outflow
valve housing was modified to accept the original bi-leaflet valves. During testing,
the stronger bi-leaflet valves maintained aortic pressure more reliably and greatly
reduced oscillations in aortic pressure that were imparted by the tri-leaflet valve com-
pliance. In addition, the outflow valve housing retained the capability to use a silicone
tri-leaflet valves after the bi-leaflet valve modifications.
Although initial tests of the bi-leaflet valve were promising, one potential fault
in their mechanical design became clear. Due to the rigid metallic leaflets used, a
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perfect seal between them could not be created upon closing. Therefore, black-flow
into the ventricle chamber arose at higher aortic pressures. In the medical field, this
is known as aortic regurgitation and can be quite common in LVAD patients (25% to
30% within the first year of implantation) [6]. Although regurgitation is common, it
was not desired during this work and a third valve revision was needed. Regurgitation
may be explored in a future work on this specific simulator. The final design moved
back to a silicon tri-leaflet valve with a harder material. Increasing the cusp thickness
and hardness to 40A both produced a valve capable of holding aortic pressure without
regurgitation as seen in Fig. 2-8.
Figure 2-7: Inverted Outlet valve in presence of LVAD back pressure.
2.1.2 Ventricle Chamber
The aforementioned ventricle chamber was a significant improvement made to the
simulator during this work. The existing chamber was refurbished by Prechtl et
al., however was lacking the ability to perform echo measurements of the chamber
valves. This echo capability was desired by Dr. Schwarz, as he drove much of the new
chamber design. Dr. Schwarz and Dr. Kolodziej completed the design and initial
manufacturing of the chamber as part of a seed funded project in 2018. This lead to
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Figure 2-8: Valve Revision Comparison
a physical prototype being delivered to the team at RIT for integration into cardiac
loop. The final components necessary for completion were the previously mentioned
valves and compliant ventricle chamber.
To begin the design, a CAD model was first created from the physical prototype.
Equipped with an accurate model, the ventricle itself was designed to seal the pres-
sure chamber and LVAD port while leaving space to displace sufficient fluid. The
seals (LVAD and chamber) were created using additional material on each end of
the chamber as seen in Fig. 2-9. During assembly, this material would displace and
form an air/water tight seal. This eliminated the need for any additional o-rings or
silicone sealants which have been the source of leaking in the past. A full model of
the chamber and its components can be seen in Fig. 2-10.
Sufficient displacement was ensured through the general chalice shape of the ven-
tricle. A rough volume displacement of 96mL (under routine compression) was de-
rived from the 3D model, which coincides with the 94mL stroke of an actual left
ventricle[28]. The true volume displacement of each "beat" will be measured during
testing using an ultrasonic flow meter. This is a key measurement to track because
actual displacement can vary widely with ventricular and aortic pressure. In addition,
measuring flow rate will aid in validating the cardiac simulators ability to represent
a human.
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Figure 2-9: Ventricle chamber section view showcasing sealing feature of ventricle at
the LVAD port
Figure 2-10: Full ventricle chamber (excluding valve assemblies)
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Once the ventricle design was complete, a similar technique to the trileaflet valves
was undertaken for manufacturing. This included a three piece printed mold and the
use of molding silicone. Also, the casting steps were carried over which produced
a functional ventricle free of any inclusions or voids. Fig. 2-11 shows the ventricle
installed in its enclosure ready for testing.
Figure 2-11: Final physical chamber assembly
The remaining components to the ventricle chamber are the valve housings. These
hold the trileaflet valves in place during operation and act as the main inlet and outlet
of the chamber. The most critical aspect of these housings is that the valves must
have enough space to open freely. This is mostly a concern with the outflow housing,
which fully encloses the aortic valve. As seen in Fig. 2-12, both the mitral and aortic
valve have ample room to function.
2.1.3 LVAD Flow Path
Unique to this cardiac phantom, there are two flow paths exiting the ventricle cham-
ber. These include the traditional aortic path and that of the LVAD. The aortic
path flows from the aortic valve location into the representative aorta. No significant
modifications were made here other than new tubing and fittings. The LVAD path
flows from the "bottom" of the ventricle, through the HMII, then intersects with the
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Figure 2-12: Valves assembled inside housing
aortic path. Revisions to the LVAD path include a simplified flow path and newly
designed outflow occlusions.
The original flow path was constructed to focus on outlet graft blockage within
the graft itself. Therefore, the outlet occlusion fixture was not directly tied to the
phantom aorta. Instead, it was placed inline between the HMII and representative
aorta as seen in Fig. 2.1. However, the aim of this work is to focus on outflow blockages
seen at the aortic graft incision site. This phenomena has been seen previously in
HMII LVAD patients [44] [31] and is primarily caused by the aortic anastomotic
suture. This suture connects the LVAD outflow graft to the aorta and is crucial to a
successful LVAD implantation.
The connection begins with an aortotomy by scalpel, Potts scissors and proximal
coronary punch. These tools result in an elliptic opening capable of accepting the
LVAD outflow graft tubing. With the opening created, an anastomosis (connection
made surgically between channels of the body) is performed between aorta and graft.
In some cases, a pledgeted mattress, surgical felt, or pericardium is used to aid in
sealing the anastomosis. After a satisfactory suture is made, blood is returned to the
aorta and any repairs are made if leakage arises [41]. In theory, this connection is free
of any surfaces that may cause excessive turbulent flow or attract platelets. However
being a foreign bio-medical device, thrombus can form at this site.
In order to model this phenomena, the occlusion fixture was converted into an
aortic junction for the phantom. This replaced the existing "aorta" which was a
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three way fitting with a pressure tap. To accommodate this change, the echo backing
plate was drilled and tapped to accept a barb fitting. This new path directly connects
to the ventricle chamber aortic output and now serves at the ascending aorta. The
outflow of the new aorta remained unchanged and still exits toward the systemic
circuit representation. The third pathway into the aorta emanates from the LVAD
and contains the modular outflow occlusion as seen below in Fig. 2-13.
Figure 2-13: Revised aortic representation
Outflow Occlusion
The original occlusion was a circular orifice that abruptly stepped down radially to
achieve a given blockage (reduction in area) percentage. This left a sharp corner
in the flow path just prior to entering the blockage fixture, which is rarely seen in
LVAD patients. Instead, outflow graft occlusions resemble a gradual narrowing and
reshaping of the graft flow path. There is still an abrupt transition, but it more
closely resembles the aortic incision rather than a circle as shown in Fig. 2-14. With
the availability of a 3D printer, these updated occlusions could be manufactured
economically on campus. The final printed version of the outlet occlusion is shown
below in Fig. 2-15.
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Figure 2-14: Left: Top section view of revised outflow occlusion showing smoothed
reduction in area. Right: Front view of outflow occlusion showing aortic incision
shape of exit path
Figure 2-15: Printed Outflow Occlusion
Inflow Occlusion
Along with a revised outflow occlusion, an inflow blockage was implemented into the
LVAD flow path. In previous works, an inflow occlusion or flow resistance was applied
to the LVAD through a clamping mechanism [16] [49]. For this work, it was desired
that the inflow occlusion be more representative of the conditions seen in vivo. The
phenomena chosen to model was the thrombus forming in the proximity of the inlet
pump fins.
A thrombus can form here for multiple reasons outlined in Chapter 1. Additionally,
a blockage forming at the inlet cannula can break apart causing fibrin structures to get
caught by the fins. Alternatively, the inlet thrombus can grow so large that it reaches
the pump fins as one structure. Fig. 2-16 shows one such obstruction, reaching well
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into the inlet cannula.
Figure 2-16: Inlet cannula thrombus extracted from patient [3]
In modeling such an occlusion in the cardiac phantom loop, one must take care
not to damage the internal components of the LVAD. Being upstream from the LVAD,
there is a chance that the simulated thrombosis could deteriorate and be suctioned
into the HMII. There is no guarantee that the LVAD would survive such an event.
Therefore, in designing the occlusions precautions were taken to ensure no foreign
objects would enter the LVAD.
The design began with generating an accurate model of the LVAD inlet fins. From
there the occlusion could be modeled in reference, creating a precise fit. Given that
there are 3 inlet fins, 33% and 66% occlusions were modeled. They both utilize the
inner ridge of the LVAD inlet for support as seen in Fig. 2-17. This retention system
ensures that the main occlusion body will not be drawn into the LVAD. To ensure
repeatable performance of the occlusions, a rigid material was chosen. A flexible
membrane or structure would have been more representative of a true thrombus, but
would be more susceptible to suction and difficult to replicate between tests. The
final printed components are shown below in Fig. 2-18
2.1.4 Systemic Circuit Representation
The final component of the cardiac phantom is the systemic circuit representation.
In the body, the systemic circuit is the sole output of the left ventricle. This network
of arteries carry oxygen rich blood throughout the body which creates significant
flow resistance. On the cardiac phantom, this resistance is created by a second fluid
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Figure 2-17: Left: Isometric view of 33% inflow occlusion and LVAD inlet. Right:
Section view of occlusion demonstrating internal support.
Figure 2-18: Left: Printed occlusions. Right: 33% inlet occlusion installed into LVAD.
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reservoir. This column is similar to the atrium chamber as seen in Fig. 2-4, however
it is a semi-sealed unit. During normal operation, a volume of air is trapped at the
top of the cylinder. This air volume serves as an air spring from the ventricle and
LVAD to push against. The compliance created mimics that of the arterial walls of
the systemic circuit. Circulatory system flow is maintained through a return channel
between the systemic and atrium column. A gate clamp is used on this channel to
facilitate flow resistance. This resistance is what tunes the aortic pressure of the
system.
2.2 Cardiac Signals
During operation of the cardiac phantom, four signals are captured for post process-
ing. These include heart sounds, ventricular pressure, aortic pressure, and flow.
2.2.1 Heart Sounds
Heart sounds are captured through the use of a digital stethoscope, specifically
the Thinklabs One (Thinklabs, CO). This stethoscope utilizes a capacitive electro-
mechanical transducer to store heart sounds. In essence, the patient’s heart sounds
induce vibrations in a capacitive diaphragm causing changes in capacitance. These
fluctuations are then converted to a sound recording and stored in a digital format.
This technology is very accurate at transducing sound and is not as sensitive to noise
as other models. An engineering diagram can be seen in Fig. 2-19 of a capacitive
microphone. The Thinklabs One stethoscope used in this thesis work was selected
and purchased by Prechtl et al. in conjunction with his LVAD diagnostic work. The
stethoscope was used with a sound amplification level of 5 for all testing. In addi-
tion, a bandpass filter (20-2000Hz) was applied upon recording by the stethoscope.
This range is suitable for any LVAD pump speeds less than 20,000 RPM or heart
sounds which typically fall below 1000Hz. Future work involving the Thinklabs One
stethoscope may involve a more in depth exploration into the effect of sound and filter
parameters.
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Figure 2-19: Diagram of a capacitive microphone used in the ThinklabsOne Digital
Stethoscope [12]
To mimic the representative in vivo performance of the stethoscope as best as
possible, an acoustic medium was used between the cardiac simulator and device
diaphragm. The material chosen was EcoFlex 00-10, as previously used by Yost et
al. [49] and subsequently Prechtl et al. [37]. Their work asserted that a 3cm layer
of EcoFlex molded over the HMII LVAD produced similar signal attenuation to what
was observed with physiological soft tissue in vivo. This thickness was used when
encasing the LVAD because in the EcoFlex mold, the LVAD is in a similar position
as in a patient. Meanwhile at the aortic graft (outlet occlusion site), the rigid fixture
does not closely represent a patient’s physiology. Therefore, a thinner mold of EcoFlex
was used. The thinner EcoFlex mold retained a repeatable measurement environment
while reducing the chances of attenuating potentially classifiable signals. Although the
acoustic medium chosen does not incorporate all the features of an in vivo environment
(cartilage, muscle, bones, ect.) it will provide a stable and repeatable environment
for testing. In the future, the testing environment may be expanded to include such
features to better represent a patient’s acoustic characteristics.
The in vitro molds were created in two parts within cardboard frames as seen
in Fig. 2-20. The HMII and aorta representation were sealed in plastic prior to
pouring the EcoFlex silicone to prevent damaging the pump internals. Using the
actual components in creating the mold ensured minimal air gaps between the two
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halves during testing. To create the two unique halves of each mold, the bottom
was first poured up to the halfway point on the respective device. Then the silicone
was allow to fully cure. Without removing the mold or device, a sheet of plastic
film was placed across the top of the newly cured EcoFlex. This created a physical
barrier to prevent the subsequent silicone from bonding to the existing mold. Ideally
a singular block of silicone would have been used, however due to servicing needs the
mold needed to be two halves.
Figure 2-20: First half of HMII LVAD mold fabrication.
2.2.2 Aortic and Ventricular Pressure
Ideally, aortic and ventricular pressure should not be used for diagnostic purposes in
this work. However, these are still vital signals to capture and monitor throughout
testing. Their importance stems from the desire to replicate in vivo conditions as best
as possible. Therefore, the range of pressures tested had to be confirmed on the car-
diac phantom. Confirmation was obtained by using two pressure transducers. These
were both carried over from previous works, however their placement was updated
to accommodate the new ventricle chamber and aorta. TDH40 transducers utilize a
piezoresistance method of converting mirco displacements in the sensor components
to a representative voltage. In practice, the pressure seen at he transducer face causes
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stress in the internal piezoresistive material. This stress causes the material’s electri-
cal resistance to change which in turn causes a change in voltage. It is important to
note that this behavior differs from that of a piezoelectric transducer. Piezoelectric
materials directly change the electric potential across themselves in the presence of
stress, not their resistance. This piezoresistive sensitivity requires consistent contact
with what ever fluid medium it is measuring. In relation to the cardiac phantom, this
requires an air pocket between the transducer face and working fluid. This air pocket
adds compliance to the system and allows for slight back flow in the system without
a sudden vacuum being recorded by the sensor.
2.2.3 System Flow
Flow rate is a key metric used for LVAD occlusion diagnosis. Often, the LVAD can
detect a low flow state using its controller and advise the patient to seek medical
assistance. This feature is a proprietary diagnostic and speculated to be activated by
an increase in the pump’s current draw. Also, flow rate can be detected on a doppler
echo-cardiogram once a patient arrives at the hospital for care. With a doppler echo
seen in Fig. 2-21, a cardiologist can visualize the magnitude and direction of blood
flow in the patient. With this information, valve closures, regurgitation, or blood
stagnation can be detected. These all may indicate a blockage inside or surrounding
the LVAD. These flow based diagnosis are an excellent option for patients and often
yield to successful detection. However, the scope of this work involves detection of
occlusions using only a digital stethoscope and a paired algorithm. Thus, flow rate
in the cardiac phantom will not be used in any way to aid in classification.
The system flow will still be captured during all testing cases for system validation
and potential use in future classification tasks. In addition, the flow data may aid in
the understanding of image features present in healthy or faulted spectra. All flow
data was captured with a non-fluid contact Transonic Emtec ultrasound flow sensor
so as to not disturb the LVAD flow path.
For final validation purposes, the revised simulator was compared to a Wiggers
diagram. The Wiggers diagram is a specific chart used to teach cardiac physiology
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Figure 2-21: Sample image of heart using a doppler echo-cardiogram
Figure 2-22: Sample Wiggers diagram of healthy patient [23]
and typically contains arterial, ventricular, and aortic pressure, ventricle volume, and
electrocardiogram. Plotted against time these signals clearly show how the heart is
moving through one cycle. An example Wiggers diagram can be seen below in Fig.
2-22.
The Wiggers diagram for the cardiac simulator does not contain ventricle volume
or arterial pressure, however it still represents the cardiac cycle well. Also, with the
presence of the LVAD the mean aortic pressure is raised above the ventricular. This
phenomena can be seen in Fig. 2-23. In addition, the ventricular pressure is lower
52
Figure 2-23: Simulator pressure curves recorded at 50BPM with LVAD
than that in the healthy Wiggers diagram. This is consistent with weakened ventricles
present in LVAD patients.
Overall, the revisions to the original cardiac simulator culminate in a repeatable
and modular LVAD testing environment. The in vitro simulator includes all relevant
biological signals (EKG, aortic pressure, and ventricular pressure) and best represents
the pulsating flow of the left ventricle. In addition, the simulator incorporates modular
components (occlusions, valves, and LVAD) that can be changed based on the desired





Pertinent signals from the cardiac simulator must first be processed prior to fault de-
tection. These processing steps are largely completed in the digital domain, leveraging
polyphase re-sampling, ensemble averaging, filtering and time-frequency transforma-
tion. The following chapter outlines each step as it pertains to in vitro data collected
from the cardiac simulator. Much of the work outlined was first implemented by
Prechtl et al. however it is outlined here for comprehension and completeness of this
thesis.
3.1 Signal Classification
In beginning any processing technique, it is critical to first identify the nature of the
signal. In the case of the representative heart sounds and EKG traces captured from
the cardiac phantom, they must be classified as either stationary or non-stationary.
Stationary signals are identified by their non-varying periodic nature. Each subse-
quent period of data is identical to the last and this pattern continues indefinitely.
In a physical medium, each period is not always the exact same point to point due
to noise, but the same general shape is preserved. For example, vibratory signals
emanating from an internal combustion engine at a constant RPM are often classified
as stationary. Variations in the signal arise from the compression, expansion, exhaust
phase of the combustion cycle, however this periodically repeats in a predictable
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manor.
In contrast to stationary signals, non-stationary signals do not follow this periodic
nature. Without a definitive period, non-stationary signals vary indefinitely in time
and don’t follow any given pattern. These are not solely stochastic signals, but
encompass any non periodic traces such as temperature over time, vibrations, or
pressure.
The signals used in this work such as heart sounds and EKG traces are nestled
between these two classes. The stationary aspect is incorporated in the overall cyclic
nature of the human heart. Baring no abnormalities, the steps of the cardiac cycle
are predictable beat to beat with the S1 and S2 being heard each cycle. However, as
with most biological processes the general cycle repeats in a predictable manor but
the exact period of said process fluctuates. This can be directly seen in a patients
variable heart rate over even a small time window. Due to a multitude of factors
(breathing rate, temperature, fatigue levels, hydration levels, etc.) a patients heart
rate can vary multiple beats per minute (BPM) during testing. Here lies the non-
stationary aspect of the heart sound and correlated EKG trace. If the heart sounds
were treated as stationary, misalignment would quickly manifest due to cycle to cycle
period discrepancies. Therefore, this work shall treat the signal as non-stationary.
This assumption also applies to the accompanying EKG trace.
Unique to this work, there is also the LVAD component to the heart sound. As
the device is set at a constant speed, its vibratory signature is inherently stationary.
Even though this stationary component is captured and contributes to the work, the
overarching class of signal processed below is assumed non-stationary.
3.2 Ensemble Averaging
The raw audio signals captured from the cardiac simulator must first be denoised
prior to any time frequency transformation. The large amount of noise captured from
the digital stethoscope would greatly skew any potential fault features. Therefore, en-
semble averaging is the chosen method for removing the ambient noise. This method
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was selected due to the signals periodic semi-stationary nature and previous applia-
cations involving heart sounds [26]. Overall, ensemble averaging collects a given set
of periods from the full length signal. These serve as the "ensemble" and ideally all
share a similar shape. Once the ensemble is collected and aligned, a point by point
average is taken between each individual period. The resulting average is then taken
to the next step of the process.
Although the previous steps are brief, there are unique features of this work’s
algorithm which allow for high performance of the ensemble averaging routine. The
first of these characteristics is the way in which the ensembles are chosen. Given
that the algorithm is intended to be implemented on a stethoscope in the future, it
would be ideal if the ensembles were able to be selected solely using the patients S1
heart sound. However, testing various peak detection algorithms did not yield positive
results. Ambient noise and LVAD artifacts present in the raw captured audio resulted
in false peaks being detected. These false peaks would have lead to misalignment of
the ensembles, in turn diminishing the prominence of key heart sound features. The
most reliable alternative to using the heart sounds is a patients EKG measurement.
Historically, the ECG has a lower signal to noise ratio (SNR) than heart sounds and
more importantly is not effected by an LVAD. In addition, the EKG’s prominent R
wave acts as an ideal peak for segmenting cardiac cycles. Detection of these R-wave
peaks can be seen below in Fig. 3-1. The ECG signal was captured using a prototype
stethoscope outlined in the following section.
The use of ECG to determine cardiac cycles in heart sound recordings are only
made possible by using two time synced signals. Without this synchronization, one
would have to solely rely on the unpredictable results of the heart sounds. Although
these two cardiac signals are extremely common in the field, they are not always
recorded in a synchronous manor. This is not an issue on the cardiac simulator, as
both EKG and heart sounds are captured in sync. To recreate this data stream in
the field, a digital stethoscope and EKG combination is proposed. A prototype of
this device was created as part of this work to show its feasibility in generating data
able to be averaged and/or classified. The following subsection outlines the work
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Figure 3-1: ECG R-wave peak detection
completed thus far on developing such a device.
3.2.1 Electrocardiogram Stethoscope
The prototype device utilizes a conventional stethoscope mated to an external ECG
machine. The original stethoscope head was left untouched as to not interfere with
it’s finely tuned acoustics. In addition, a conventional stethoscope was selected due
to the general acceptance of their use in the medical field. The specific stethoscope
chosen was a 3M Littmann Master Classic II as seen in Fig. 3-2. This model is widely
used in the cardiac field and is the same model used by Dr. Schwarz, a partner in
this prototype development.
In order to maintain proper function of the stethoscope, the EKG modifications
could not put any unwarranted pressure on the diaphragm or bell. Therefore, a ring
was developed to hold the EKG leads on the outer edge of the stethoscope. A single
clamp onto the tubing anchor securely positions the ring without intruding on the
stethoscope’s primary function.
EKG electrodes can either be "wet" or "dry". Wet electrodes utilize a conductive
gel encased in an adhesive ring to make contact with the patient’s skin. On the other
hand, dry electrodes utilize the same adhesive ring but do not contain a conductive
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Figure 3-2: 3M Littmann Master Classic II 27" Stethoscope
gel. Wet electrodes can provide better contact when used on patients with more
body hair or irregular surfaces. However, they are not reusable and do not offer any
significant signal advantages over a properly placed dry electrode [40]. Due to their
reusable nature, dry stainless steel electrodes were chosen for the EKG ring.
An initial design was proposed utilizing three cylindrical stainless steel contacts.
The contacts were housed in a 3D printed ring surrounding the stethoscope’s bell
and directly modeled after conventional "wet" electrodes. Threaded rods were used
in order to connect the contacts to the modified EKG button caps. These cylindrical
contacts were able to detect an electrical potential, however it was intermittent and
difficult to reproduce between patients. This warranted a revision of the housing and
contacts to achieve a larger contact patch on the patients skin.
Updating the design to use curved, contacts provided 250% more surface area.
This increase in patient contact area led to a more consistent signal over the 90
second period of data collection. In addition, the signal was more easily found on the
chest as seen in Fig. 3-3.
Following a successful ECG test with the new contact design, the ring was trans-
ferred onto a digitally enhanced stethoscope for further testing as shown in Fig. 3-4.
Using the contact ring on a digital stethoscope would allow for synchronous EKG
and auscultation signals to be captured from the same device. This stream of data
allows for the EKG measurement to aid in ensemble averaging parsing. Furthermore,
a successful averaging of these test signals validates the use of EKG in parsing heart
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Figure 3-3: Subsequent revisions of the stethoscope contacts and resulting in-
crease signal consistency. Above signals were captured without a digitally enhanced
Littmann stethoscope
sounds as previously mentioned.
As expected, testing this EKG and digital stethoscope combination yielded fa-
vorable results. Using the digitally enhanced 3M Littman provided by Dr. Schwarz
and the URMC, an ensemble averaged heart sound was produced using the EKG
measurement obtained directly from the ring. This measurement was repeated on
two male subjects in the same chest location. In Fig. 3-5 it is evident that the black
averaged line matches up well with the colored ensembles. Also, when listening to the
recording there is an audible reduction in background noise with the averaged sound.
Assuming the EKG signal is available and recorded in sync with the heart sounds,
the R wave peaks are used to parse the corresponding heart sounds. The cycles begin
as the period between each subsequent R wave peak. This method theoretically
produces cycles of equal length and therefore an ensemble that is prepared for point
by point averaging. However, this assumes that the heart rate of the patient or
cardiac phantom is constant. As mentioned previously, this is far from reality given
the non-stationary nature of heart rate. To remedy this cyclic discrepancy each cycle
must be re-sampled, producing an ensemble with homogeneous periods.
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Figure 3-4: URMC digitally enhanced 3M Littmann stethoscope and attached EKG
ring.
Figure 3-5: Successful ensemble averaging of heart sounds with digital stethoscope
and attached EKG ring.
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3.3 Polyphase Decomposition
Polyphase Decomposition accomplishes the previously mentioned re-sampling without
the degredation of signal features. Initially, the raw cycles may have vastly different
number of samples within them due to the variation in period. Even so, they are all
time scaled from 0 to 1 in order to maintain signal length throughout the re-sampling
process. In addition, the time scaling aligns each cycle to one another based on the R
wave peak. Now, the cycles vary based on sampling rate rather than signal length. For
example, imagine two cycles (A & B) parsed from the original auscultation recording.
Originating from the same signal, both A & B have the same sampling rate (1000Hz).
However, based on the signals non-stationary properties, A is 950 samples long while
B is 1050 samples long. Time scaling both from 0 to 1 alters the sampling rate of the
data. Now, cycle A is discretized at a rate of 950Hz and B at 1050Hz. Here lies the
need for re-sampling each cycle. If the cycles are to be averaged point by point, they
need to share the same amount of points (sampled at the same rate)
The process of re-sampling involves two steps, upsampling and downsampling. In
a general sense, upsampling involves adding samples to the data between the existing
points. Zeros are first inserted, then a smoothing low pass filter (to eliviate compres-
sion of the spectrum) aligns the points with the existing data. Points are added by a
factor of L known as the upsample factor. On the other hand, downsampling involves
removing points from the data by a factor of M. In addition, a low pass anti-aliasing
filter is commonly applied to preserve the signal features. The selection of L and M





The resampling factors in this work are derived on a cycle by cycle basis. In order
to maintain a rational factor each time, the least common multiple (LCM) between the
mean and individual cycles is used. For example, if the mean rate of the unprocessed
ensemble is 4Hz, and the cycle to be analyzed is at 10Hz, the least common multiple
would be 20 (the lowest number divisible by both components). Thus 𝐿 = 2,𝑀 = 5,
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bringing the cycle rate up to 20Hz before downsampling to 4Hz. The same processes
is followed for the higher sample rates used on the cardiac simulator but at much
larger magnitudes.
This generic resampling procedure is a great method for altering sample rates
cycle to cycle, however there are drawbacks related to this work. The first being
computation cost. The cycles considered are originally sampled at 10kHz in order
to capture the greatest frequency spectrum available. Therefore the length of each
heart sound cycle can become considerably long. In addition, these cycles must be
upsampled according to corresponding mean LCM, further enlarging the cycle size.
The other drawback to this method is that the data must be filtered twice, each time
it is sampled (up & down). Secondly, a filter must be derived and applied twice for
each cycle. Having to derive and apply the ideal filter for each cycle quickly increases
the computation time.
The solution carried over from Prechtl’s work is known as polyphase decomposition
[37]. In this algorithm, only one filter is is derived and applied to the cycle after re-
sampling. This filter is selected based on the more restrictive Nyquist frequency
condition between the upsampling and downsampling events. A kaiser window serves
as the general form of the filter, resulting in a low pass behavior with a transition
band defined as such.
𝑃𝑎𝑠𝑠𝑏𝑎𝑛𝑑 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 [𝜋 𝑟𝑎𝑑/𝑛] : 𝜔𝑝 (3.2)
𝑆𝑡𝑜𝑝𝑏𝑎𝑛𝑑 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 [𝜋 𝑟𝑎𝑑/𝑛] : 𝜔𝑠 (3.3)
𝑇𝑟𝑎𝑛𝑠𝑖𝑡𝑖𝑜𝑛 𝐵𝑎𝑛𝑑 (𝑇𝐵) [𝜋 𝑟𝑎𝑑/𝑛] : ∆𝜔 = 𝜔𝑠 − 𝜔𝑝 (3.4)







Unique to polyphase decomposition, 𝜔𝑐 is selected based on the value of R. For
example, if 𝑅 > 1 the cycle is being resampled to a smaller rate (𝐿 > 𝑀). Thus,
the TB center frequency is constricted by the downsampling rate M. On the other
hand, if 𝑅 < 1, the cycle sampling rate is increasing overall(𝐿 < 𝑀). Therefore, 𝜔𝑐 is
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now restricted by the upsampling rate L. Following this convention guarantees that
both Nyquist conditions will be satisfied (the condition being that the resampling
rate must not exceed half of the original signals sampling rate). This preserves low
frequency components while eliminating aliasing of high frequency components.
Further restrictions on the filter design (mainly 𝜔𝑐) originate from the spectral
components observed during testing. The highest frequency content seen in HMII
LVAD patients was roughly 500Hz [37]. Therefore, the resampled Nyquist (𝜔𝑐) must
be placed sufficiently distant from this desired frequency content as to not skew
any results. The selected sampling rate of 10kHz is sufficiently high to satisfy this
requirement and achievable with the data acquisition equipment. Readers interested
in a more detailed explanation of this re-sampling technique may refer to Prechtl’s
thesis work on the subject.
As a result of the previous scaling, re-sampling, and filtering, the ensemble of
heart sound cycles may now be averaged point by point. At this point in the process,
a majority of signal noise and high frequency harmonics have been removed from the
signal. Therefore, the ensemble average is ready to be transformed into the time-
frequency domain.
3.4 Continuous Wavelet Transform
Signals in the time domain are useful for many applications. Their statistical param-
eters such as mean, standard deviation, and maximum are often leveraged in classi-
fication applications. Their significance is especially relevant in stationary systems
such as power generation turbines. For example, observing a rise in the amplitude of
a given vibration signal above a threshold can indicate failure within the system.
However, not all systems can be fully classified using time based techniques. When
transient and chaotic behavior are present (such is the case in this work), time-
frequency transformations are preferred. The short time fourier transform (STFT)
and continuous wavelet transform (CWT) are two popular time frequency transfor-
mations used in LVAD classification [46] [33].
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The STFT is computed by translating (in time) a windowing function across the
signal and performing a Fast Fourier Transform (FFT) on the given window. The
FFT decomposes the windowed signal into a set of trigonometric functions of various
frequencies and amplitudes.




𝑤ℎ𝑒𝑟𝑒 : 𝑥(𝑡) = 𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑖𝑚𝑒 𝑠𝑒𝑟𝑖𝑒𝑠 𝑠𝑖𝑔𝑛𝑎𝑙
𝑡 = 𝑡𝑖𝑚𝑒 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝜔 = 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝜏 = 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟
𝑤 = 𝑤𝑖𝑛𝑑𝑜𝑤𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛
The main drawback to the STFT is the inverse relationship between time and
frequency resolution. As one increases the frequency resolution by lengthening the
windowing function, there are less data points in time for the windowing function to
translate across. Inversely, if the windowing function is shortened, the time resolution
increases at the cost of diminished frequency resolution. In relation to this work, the
fault indicating components are not necessarily known prior to testing. Therefore, it
is advantageous to avoid resolution limitations in the time and/or frequency domain.
Therefore, the alternative transformation (CWT) is used throughout this work.
The CWT produces a similar result as the STFT (basis of trigonometric func-
tions), however the CWT utilizes a varying window as opposed to the fixed window
of the STFT. The ability to scale as well as translate the CWT window results in a
multi-resolution output.
The CWT begins with a function known as the mother wavelet. This function
is what all other functions in the decomposition are based upon. These resulting
functions are referred to as daughter wavelets. Each daughter wavelet is simply a
translated and scaled version of the mother defined by
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𝑤ℎ𝑒𝑟𝑒 : 𝑥(𝑡) = 𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑡𝑖𝑚𝑒 𝑠𝑒𝑟𝑖𝑒𝑠 𝑠𝑖𝑔𝑛𝑎𝑙
𝑡 = 𝑡𝑖𝑚𝑒 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝑎 = 𝑠𝑐𝑎𝑙𝑖𝑛𝑔 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝑏 = 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝜓 = 𝑚𝑜𝑡ℎ𝑒𝑟 𝑤𝑎𝑣𝑒𝑙𝑒𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑥 𝑐𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑒
𝛾(𝑎, 𝑏) = 𝑤𝑎𝑣𝑒𝑙𝑒𝑡 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠
The scaling parameter defines the degree of compression in the daughter wavelet.
Larger scaling parameters result in a lower frequency and amplitude daughter wavelet.
This characteristic is shown below in Fig. 3-6
Figure 3-6: Effect of scaling on Morlet mother wavelet
The translation parameter shifts the daughter wavelet on the time axis as seen in
Fig. 3-7. This parameter acts similarly to the windowing function used in Fourier
transforms by focusing the decomposition on a particular point in time.
The mother wavelet selected for this work is the Morlet basis which draws parallels
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Figure 3-7: Translation of Morlet mother wavelet
to trigonometric functions of the STFT and has showed promise is previous works







𝑍𝑒𝑟𝑜 𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 : |𝜓(𝜔 = 0)|2 = 0 (3.9)
𝑇𝑖𝑚𝑒 𝐷𝑜𝑚𝑎𝑖𝑛 𝑍𝑒𝑟𝑜 𝑀𝑒𝑎𝑛 :
∫︁
𝜓(𝑡)𝑑𝑡 = 0 (3.10)
𝑅𝑒𝑔𝑢𝑙𝑎𝑟𝑖𝑡𝑦* : 𝛾(𝑎, 0) 𝑑𝑒𝑐𝑎𝑦𝑠 𝑎𝑡 𝑎𝑛+2 (3.11)
𝑤ℎ𝑒𝑟𝑒 : 𝐹{} = 𝐹𝑜𝑢𝑟𝑖𝑒𝑟 𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚
Admissibility ensures that the wavelet transform can be used to reconstruct the
signal without loss of information. In turn, the transformation is injective and all
time domain content is preserved within the valid region. Zero frequency and zero
mean can be combined to show that the mother wavelet is an oscillating wave centered
about the origin. Therefore, the convolution of the mother or a given daughter (trans-
lated and scaled) basis function onto the signal will act similar to a bandpass filter.
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Lastly, regularity governs the smoothness and decay rate of the mother wavelet. This
constricts the shape of the wavelet so as to ensure it "vanishes" upon transformation
with the signal. Therefore, the basis function does not skew the original signal. In
addition, the smoother the basis function becomes the less fidelity it has at higher
frequencies. This leads to a potential drawback of the CWT, having finer resolution
at lower frequencies and more course resolution at high frequencies.
Due to the continuous translation of the CWT, the resulting scaling matrix is
largely effected by when (in time) features manifest in the transformed signal. How-
ever, the time scaling (0 to 1) and polyphase decomposition performed prior to trans-
formation reduces the effect of signal timing. Another down side to the CWT is
the computational resources that it requires. Therefore, it is wise to choose the op-
timal parameters to ensure complete spectral coverage without creating redundant
features. The parameters in question govern the resulting band pass filter bank.
They include minimum center frequency (CF), maximum center frequency, and filter
bank discretization.
To ensure maximum usable range of the CWT, the maximum CF (minimum scale)
was placed as close as possible to the Nyquist limit without inducing any edge effects
in that region. On the other hand, the minimum CF selection was dictated by the
lowest known frequency seen during in vitro testing (2̃0Hz) [37]. The ideal value for
this maximum scale (minimum CF) was ensemble dependent and directly resulted in
the wavelet’s standard deviation. Finally, the filter banks discretization was chosen
to be 20. This allowed the CWT to obtain sufficient resolution without exceeding
the available computational resources. These parameters were carried over from the
work of Prechtl et al. and intereseted readers may reffer to his work on the subject
[37].
The final CWT consideration is the effect the cone of influence (COI) has on the
resulting spectrum. The COI is defined as the region on either extrema of the time
scale where the spectrum is considered invalid. Invalidity emanates from the wavelet
propagation being unable to be fully defined over a given window. Take for example a
500Hz frequency component found in the transformed signal to be centered at the 50th
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sample. If a 200 sample daughter wavelet is to be convoluted with the transformed
signal, there will be a 50 sample surplus before time 0. Therefore, the resulting
transformation would not be valid. This COI phenomena decreases with time and
vanishes futher into the signal. In relation to the in vitro signals, it is imperative that
the features in question (mainly the S1 and LVAD effects) are omitted from the COI.
This is accomplished by overlapping each cycle by 40% with its adjacent cycle. As
shown by Prechtl et al. [37] this amount of overlap sufficiently moves the S1 into the
valid CWT region. Translation takes place after scaling and polyphase decomposition





Once the acoustic signal has been processed in both the digital and frequency domain,
the result is a spectral image. This is image must then be classified as "healthy"
or "faulted". The following chapter outlines the methods used to arrive at such
a classification without the need for manual extraction of image features. Instead,
the entire spectral image is used and the classifier learns to use the most important
features on its own.
4.1 Binary Classification Trees
One of the many classification algorithms used in the field of machine learning is the
Classification Tree (CT). At its most basic level, the CT functions like a logical flow
chart. A sample begins at the root node and depending on its input representation
(features), it follows a given path through intermediate nodes until it eventually
reaches a leaf node. In binary applications, this simple form of tree can work very
well and takes relatively low amounts of training data to learn. For example, Table
4.1 and Figure 4-1 showcase a simple case where a binary CT could be useful in
determining whether or not to hold class outdoors. Samples 1-6 would begin at the
root node and move downwards and depending on their features, either indicate class
inside or out. For example, data point 1 contains high winds, hot temperatures,
and a sunny outlook. This combination of features may indicate indoor class based
71
on the first intermediate "wind" node. However, data point 2 has low wind, hot
temperatures, and a sunny outlook. Based on the tree structure this point may make
it all the way down the outdoor leaf node.
Table 4.1: Sample data for classification tree example
Data Point Temperature Wind Outlook Class?
1 Hot High Sunny Outdoor
2 Hot Low Sunny Outdoor
3 Cold Low Rain Outdoor
4 Cold High Rain Indoor
5 Cold Low Rain Indoor
6 Hot High Rain Indoor
Figure 4-1: Binary Classification Tree Example
At a high level, the training of such a tree involves selecting what features (tem-
perature, wind, outlook) to split each node on and in what order. This process
involves the use of Entropy and the Gini Index of each node. The Entropy of the
node represents the uncertainty in the tree prior to selecting the next split. It uses the
proportion of each final class (p) contained within an intermediate node as follows.







The Gini index accomplishes the same goal as Entropy however uses a different
derivation. Both are largely interchangeable when training classification trees.




From these measures of node uncertainty, one can calculate the information gain
and select the optimal binary feature to split the node with. As mentioned previously,
these tree architectures can be very useful in simple situations. However, in the realm
of image classification, a more complex method is often required.
4.2 Boosted Classification Trees
Unlike the aforementioned binary classification trees, boosted trees gain their in-
telligence from hundreds or thousands of "weak" learners as opposed to a select
few "strong" features. Alone the weak learners only operate marginally better than
random classification (50% accuracy), however when they work together the weak
learners can outperform a few stronger features.
As with most computational research fields, there are a plethora of algorithms
that accomplish this concept of boosting in a classification tree. In this work, one
of the original boosting methods was applied to the LVAD data set. This being the
AdaBoost algorithm developed by Viola et al. [45] in their work on facial recognition.
In the following subsection, a detailed explanation of the algorithm and its learning
method are outlined.
4.2.1 AdaBoost Algorithm
The following explanation of AdaBoost is the culmination of multiple sources includ-
ing lectures by Ptucha [38] and Schapire [39].
The algorithm begins, as all do, with the training features and their corresponding
ground truths.
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𝑔𝑖𝑣𝑒𝑛 : (𝑥1, 𝑦1)...(𝑥𝑚, 𝑦𝑚) (4.3)
𝑤ℎ𝑒𝑟𝑒 : 𝑦𝑖 ∈ {−1,+1} : 𝑥𝑖 ∈ 𝑋 (4.4)
In this work, the X domain consists of the 1x2500 pixel vectors (reduced resolution
unfolded spectral images). This specific image resolution will be addressed in section
4.3 below. The ground truths y are either "-1" for faulted or "+1" for healthy. Lastly,
m represents the number of training samples. With the training samples defined, the
main training loop begins.
𝑓𝑜𝑟 : 𝑡 = 1, ..., 𝑇 ; (4.5)
𝑐𝑜𝑛𝑠𝑡𝑟𝑢𝑐𝑡 : 𝐷𝑡∀{1, ...,𝑚} (4.6)
For each training round t of T, a distribution 𝐷𝑡 is created for all m training
samples. This distribution will be mentioned later, however for now know that it
involved applying weights to each training sample.
With the distribution created for all training samples, a weak hypothesis or feature
is tested for all training samples.
ℎ𝑡 : 𝑋 → {−1,+1} (4.7)
Consequently, for each training round, weak feature, and training sample a ℎ𝑡
value is assigned. The convention of X is followed with "-1" for faulted or "+1" for
healthy.
With the classifiers prediction on all training samples ℎ𝑡, the error is then deter-
mined across all m samples.
𝜖𝑡 = 𝑃𝑟𝐷𝑡 [ℎ𝑡(𝑥𝑖) ̸= 𝑦𝑖] (4.8)
Where 𝜖𝑡 represents the probability of the weights contained in 𝐷𝑡 along with the
weak feature prediction ℎ𝑡 yielding an incorrect classification. Therefore, the user
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would like to minimize 𝜖𝑡.
Once the optimal ℎ𝑡 is found, it is stored for that give t out of T training rounds.
Once the loop has completed T rounds, all the ℎ𝑡 are combined into 𝐻𝑓𝑖𝑛𝑎𝑙 which is
then used for classification of unknown testing samples.
The main training loop depends on a distribution, 𝐷𝑡, which contains a distinct
weight for each training sample. This weight is updated each iteration and is unique





In subsequent training rounds, 𝐷𝑡+1 is updated such that weights of incorrectly
classified samples are increased while correctly classified sample weights are decreased.
Mathematically, this operation is accomplished with the clever use of the exponential











) > 0 (4.11)
When a correct prediction is made by ℎ𝑡, either faulted or healthy, the result of
ℎ𝑡 * 𝑦𝑖 = +1. Thus, the exponential term becomes exp(−𝛼𝑡) which regardless of
the positive learning rate 𝛼 is smaller than 1, hence decreasing the training sample
i weight in 𝐷𝑡+1. Inversely, if ℎ𝑡 incorrectly classifies the training sample i, then
ℎ𝑡 * 𝑦𝑖 = −1 and exp(−𝛼𝑡) is greater than 1. This increases the weight of training
sample i in the subsequent distribution 𝐷𝑡+1.
With the weights all learned over the course of T training rounds, a final predictor
is compiled. The unknown sample x is then classified based on majority vote between







The following example aims to further explain the AdaBoost algorithm and how it
learns to leverage the power of weak learners. Also, the specific example and graphics
are work of Schapire et al. [39].
Imagine a sample data set with 10 points evenly split between two classes. The
data has only two dimensions and due to the nature of weak learners, only a threshold
decision can be made on either dimension.
The first step is to assign the initial distribution of weights to each training sample.
𝑚 = 10 → 𝐷1 = 0.1∀(𝑥𝑖, 𝑦𝑖) (4.13)
Then, the first predictor (ℎ1) is selected that minimizes the overall error (𝜖1). Fig.
4-2 shows that 3 samples are incorrectly classified.






) = 0.42 (4.14)
Figure 4-2: Initial AdaBoost iteration, predictor ℎ1
This concludes the initial iteration. Now for the second, the weights are first
adjusted according to their correctness of classification. The 3 incorrect samples have
their weight increased while the 7 correct sample weights are decreased.
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𝐷2𝑖𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡 = 𝐷1 exp(−𝛼1) = 0.152 (4.15)
𝐷2𝑐𝑜𝑟𝑟𝑒𝑐𝑡 = 𝐷1 exp(𝛼1) = 0.066 (4.16)
After 𝐷2 is formed, a new predictor ℎ2 is derived to minimize classification error in
accordance to the updated weights. Fig. 4-3 is once again chosen on the X dimension
and leads to 3 incorrect samples. However, it is important to note that all three
samples with a larger 𝐷2 value were correctly classified in this training round. This
clearly shows the weights effect on selection of the predictor threshold in subsequent
training rounds. With the selected ℎ2, the following parameters can be calculated.






) = 0.65 (4.17)
Figure 4-3: Second AdaBoost iteration, predictor ℎ2
Following the selection of the predictor and determining the correct and incorrect
samples, the weights of each sample are updated. This time, 4 different numerical
weights are distributed amount the training samples. Let ii denote two subsequent
incorrect classifications, ci denote a correct then incorrect classification, and so on.
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𝐷3𝑖𝑖 = 0.152 exp(−𝛼2) = 0.2873 (4.18)
𝐷3𝑖𝑐 = 0.152 exp(−𝛼2) = 0.0783 (4.19)
𝐷3𝑐𝑐 = 0.066 exp(𝛼2) = 0.0365 (4.20)
𝐷3𝑐𝑖 = 0.066 exp(𝛼2) = 0.1341 (4.21)
These new weights contained in 𝐷3 result in the final predictor for training round
3 (ℎ3). Fig. 4-4 shows the training error and 𝛼 values to be the following.






) = 0.92 (4.22)
Figure 4-4: Third AdaBoost iteration, predictor ℎ3
Even more clearly than Fig. 4-3, the third iteration showcases the power of dis-
tributing the weight onto the incorrectly classified samples. There are still three
incorrect samples when predicting with weak feature ℎ3, however the three samples
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have relatively very small weights. Therefore, either ℎ1 or ℎ2 should classify those
incorrect samples and leave the rest to ℎ3.
Completion of training is controlled by the user and is either a set number of
training rounds or training error criteria. In this example, only three rounds were
required due to the low dimension of the training data. However, hundreds to thou-
sands of training rounds may be needed for higher dimensional representations such
as images.
With the three rounds complete, 𝐻𝑓𝑖𝑛𝑎𝑙 is compiled to be,
𝐻𝑓𝑖𝑛𝑎𝑙(𝑥) = 𝑠𝑖𝑔𝑛(𝛼1ℎ1(𝑥) + 𝛼2ℎ2(𝑥) + 𝛼3ℎ3(𝑥)) (4.23)
or show visually in Fig. 4-5 and Fig. 4-6.
Figure 4-5: Final AdaBoost classifier
Figure 4-6: 𝐻𝑓𝑖𝑛𝑎𝑙 Classification Predictions
In the end, the three week learners work well together to provide a classifier capable
of excellent training set performance. Assuming the hyper parameters are reasonably
tuned, this training performance often translates to held out test sets (data not seen
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by the classifier during training) as well. On the topic of hyper parameters (tuning
values within the learning algorithm), the AdaBoost algorithm has a handful of key
parameters. First is learning rate. This is not present in the previous equations,
however it is incorporated into the selection of the optimal predictor ℎ𝑡. In the
derivation of ℎ𝑡, a optimization technique such as gradient decent is used to arrive
at the minimum of a given cost function. At a high level, gradient decent uses a
multitude of partial derivatives to modify a classifier’s properties in the correct way
to reduce error. Each iteration, the algorithm descends the cost function gradient in
the steepest direction and increments the parameters under its control by a prescribed
amount. This prescribed amount is controlled by the learning rate. Too high of a
learning rate and the algorithm may settle at a sub-optimal minimum or become
unstable. Too low of of a learning rate without sufficient iterations can miss the
minimum cost all together or be very inefficient.
Another hyper parameter within the Adaboost algorithm is the number of learning
cycles. Denoted in the above example as a subscript t, the learning cycles can be
thought of as the number of weak features trained in the overall classifier. This is
arguably the most critical feature for tuning. Too many features can lead to over
fitting and poor results on unseen test sets. On the other hand, too few weak learners
does not provide the advantage they unlock.
4.3 LVAD Spectral Classifier
Building off the previous base knowledge of boosted classification trees, this section
explores the specific application to the collected LVAD data. The Adaboost algorithm
and training process were all implemented with the help of Matlab’s machine learning
toolbox. This toolbox provided functions with accessible tuning parameters, enabling
efficient application of the algorithms. In addition, the Matlab functions mimic the
processes outlined in the previous section.
In order to classify the spectral images, they were first pre-processed to derive
defined feature vectors. This process began with generating a Matlab figure directly
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from the functions created by Prechtl et al. [37]. The functions included all signal
processing such as ECG parsing, ensemble averaging, and the continuous wavelet
transform. These figures were then converted to gray-scale and normalized from 0-1.
Normalizing each image to itself ensured that amplitude variations between testing
sessions would not skew results. After normalization, the figures were downsampled
to a resultion of 50x50 pixels. Two alternative image resolutions were tested and are
shown in Fig. 4-7, 28x28 and 125x125. The first option originated from previous work
with Prechtl’s collected LVAD data. This resolution performed well on the spectral
data (roughly 92.5% accuracy) and was sufficiently trained with the available 800
training data points. However, due to the larger amount of data anticipated in this
work, higher image resolution was desired. In doing so, it was expected that finer
features would be detected by the classifier and lead to a higher accuracy. However,
higher resolutions require significantly higher levels of computing power and more
importantly available training data. Therefore, the resolution was kept at 50x50,
eliminating the 125x125 option. Future work may benefit from exploring alternative
classifier resolutions.
Figure 4-7: Spectral Image Resolution Comparison
After preparing the 50x50 images, they were unfolded into 1x2500 numerical vec-
tors. The reshape Matlab command was used for each image to maintaining consis-
tency. These pixel vectors were then stored in a larger mx2500 matrix which contained
all m training or testing samples to be used in a given case.
With the images correlated and prepared for training/testing, the boosted classi-
fication tree could then be trained. Training the classifier was accomplished by the
fitensemble function in Matlab. This function trains a given ensemble of boosted
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classification trees to most accurately classify a provided training data set. When
the output "tree" is then called to classify an unknown testing sample, the individual
trees vote and the majority class is taken. The two tuning parameters used for the
classifier were learning rate and training rounds. The final values used for these were
0.8 and 1200 respectively. Learning rate was dictated by training efficiency while
training rounds was selected to balance test set accuracy between all cases. Evidence
of these selections can be seen in the following chapter.
Overall, the classification process follows the path outlined in Fig. 4-8 below.
This process was maintained for every image regardless if it was used for training
or testing. A key aspect of this process is that at no point is a region of interest
selected. Instead, the entire down-sampled images is used and it is up to the classifier
to discern which features (pixels) are important.




The following section outlines the final data, classifier, and results obtained in this
work.
5.1 Data Collection
As mentioned in Chapter 2, data for this work was collected on a revised cardiac
phantom. Audio measurements were taken at two specific locations, the aorta and
LVAD. The location of the stethoscope was marked on the EcoFleX housings and
repeated between each testing scenario as seen in Fig. 5-1.
Figure 5-1: Stethoscope Measurement Locations (Left: Aortic, Right: LVAD)
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Identical blockage scenarios were tested at each measurement location for com-
pleteness and to test the robustness of the classification method. To simplify the
data labeling during testing, a 4 digit code was created to represent the heart rate,
location, and blockage case for each data point. This code is outlined below in Table
5.1. For example, if a data set is labeled with 2108 this denotes a 70BPM sample
recorded at the LVAD with no inlet blockage and 80% blockage at the aorta.
Table 5.1: Data identification legend
Heart Rate (BPM) Location Inlet Outlet
50 (0) Aorta (0) 0% (0) 0% (0)
60 (1) LVAD (1) 66% (1) 80% (1)
70 (2)
var(3)
The specific data obtained from the test environment is outlined below in Table
5.2 and Table 5.3.
Table 5.2: Test and Training data collected from aortic site
Heart Rate Systolic Pressure Diastolic Pressure 000 008 060
BPM mmHg mmHg Train/Test Train/Test Train/Test
50 90-130 60-80 200/80 200/80 200/80
60 90-130 60-80 200/80 200/80 200/80
70 90-130 60-80 200/80 200/80 200/80
variable 90-130 60-80 0/120 0/120
Table 5.3: Test and Training data collected from LVAD site
Heart Rate Systolic Pressure Diastolic Pressure 100 108 160
BPM mmHg mmHg Train/Test Train/Test Train/Test
50 90-130 60-80 200/80 200/80 200/80
60 90-130 60-80 200/80 200/80 200/80
70 90-130 60-80 200/80 200/80 200/80
In both Table 5.2 and Table 5.3, the quantity of data points reflects a repeated
process for all scenarios. Each 200 point training set was broken up into 4, 50 point
cases as seen in Table 5.4. Similarly, the 80 point validation sets were broken into 4,
20 point cases. Each data point contains 15 seconds of stethoscope recording ensemble
averaged into a single heart sound.
For each case, the following procedure was followed.
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Table 5.4: Training and Testing aortic pressure ranges






1. Install prescribed blockage
2. Fill system and purge any remaining air
3. Place stethoscope on measurement location (aorta or LVAD)
4. Set simulator heart rate
5. Fine tune simulator pressures and gate clamp to achieve desired ventricle and
aortic pressures
6. Begin data acquisition at 10kHz
7. Allow for either 50 training or 20 testing samples to be collected.
8. End data acquisition
During the data acquisition step, the LabVIEW user interface developed for this
work automatically records and saves a sample every 15 seconds. Therefore, training
data sets were recorded continuously for 750 seconds while testing sets lasted 300
seconds. Figure 5-2 is provided below to better understand the nomenclature used to
reference the data moving forward. A similar hierarchy can be shown for the testing
data set.
It is important to note that the training and testing data were taken independent
of one another. The system was either drained and refilled or let sit for days at a
time before the next set of data was acquired. This separation between training and
testing data sets provides a robust test environment for the classifier. In addition,
keeping the two sets independent is the general convention for classification tasks and
further validates the classifier’s performance.
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Figure 5-2: Experimental data hierarchy
Finally, the case denoted as "variable" does not simply contain a predetermined
mix of heart sounds from each of the collected heart rate samples. Instead, the variable
data was generated with a specific controller which varied the simulator heart rate
during testing. Heart rates varied continuously between 50 and 70 BPM and followed
a standard Gaussian distribution. As with the other testing cases, the simulator was
drained and re-filled prior to the collection of this variable set.
5.1.1 Classification Data
Once the experimental data was collected and processed into spectral images via
the CWT, it was sorted into multiple sets prior to classification. These various sets
provided a robust training/testing environment for the classification method to be
evaluated. In general the data was split only on heart rate, however a more detailed
outline is provided in Table 5.5. Since all blockage and heart rate cases were tested
at both the aortic and LVAD site, the following nomenclature will be used to denote
the measurement site and blockage. The letter a and v denote aorta and LVAD
respectively. Then, o and i denote outlet or inlet blockage. For example, T50ao
represents a training/testing case using only 50BPM images taken at the aortic site
with the outlet blockage installed. The second set of cases denoted LOO, signifies
that a given heart rate was omitted from the training data then used to test the
classifier. These cases are known as "leave one out" in machine learning literature.
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Finally, the all case included all heart rates for training and testing.
Table 5.5: Classification Cases
Case Description Training/Testing
all all heart rates included 1200/640
T50 only 50BPM used for training and testing 400/160
T60 only 60BPM used for training and testing 400/160
T70 only 70BPM used for training and testing 400/160
LOO50 Leaving 50BPM out of training, testing with 50BPM only 800/80
LOO60 Leaving 60BPM out of training, testing with 60BPM only 800/80
LOO70 Leaving 70BPM out of training, testing with 70BPM only 800/80
5.2 Classifier
5.2.1 Hyper Parameters
The final regression tree classifier was derived using the method previously outlined
in Chapter 4. However, tuning of specific hyper parameters was needed to arrive at
a favorable test set accuracy. The first of these parameters was the minimum leaf
size (minleafsize) of the boosted classification tree. The minimum leaf size is the
predefined limit to split an intermediate node given the number of observations in
one of the leaf nodes is less than the minimum leaf size. Generally speaking, a low
minleafsize leads to over fitting as the tree makes more and more splits to bring the
leaf observations under the minimum size. On the other hand, a large minleafsize can
lead to poor test set accuracy with shallower trees being learned.
To select this value, a template tree was tested for a variety of minimum leaf sizes.
The test set accuracy was then compared between the "ao" cases (outlet occlusions
measured at the aortic site). This blockage and measurement combination produced
the most repeatable results and was therefore chosen to help optimize the classifier. A
1D parameter sweep was conducted on a 200 learning cycle tree in order to visualize
the trend between minimum leaf size and test set accuracy. Figure 5-3 did not show
any clear trend between leaf size and test set accuracy. A potential reason for this lack
of a trend is that the classifier arrives at a focused tree no matter the hyper parameter
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value. Therefore, a value of 60 was chosen in that each "ao" case performed well with
this value.
Figure 5-3: Minimum leaf size exploration
Initially a learning rate of 0.8 was used to conduct the parameter sweep of learning
cycles. This provided a baseline for repeatable testing when varying the number of
learning cycles performed during training. Again using the consistent "ao" cases,
Fig. 5-4 shows a flattening trend in test set accuracy over 1000 cycles. Therefore,
1200 learning cycles was used to train all following classifiers. The test set accuracy of
"T70ao" does continue to increase beyond 1200 learning cycles, however this relatively
small increase in accuracy does not outweigh the risk of over fitting the classifier.
With the learning cycles tuned, the final classifier parameters can be outlined below
in Table 5.6
5.2.2 Classifier Visualization
The provided example in Chapter 4 of an AdaBoost application was simple to visualize
in 2 dimensions. The X and Y axis provided clear and concise decision boundaries
between the "+" and "-" symbols and combining the three weak learning provided
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Figure 5-4: Determination of optimal number of learning cycles
Table 5.6: Final Classifier Parameters
Parameter Value
Learning Rate 0.8






a simple concise visual. However, like many high level mathematical concepts, the
human perception of 3 dimensions quickly limits the ability to visualize the classifiers
produced in this work. With the 50x50 image (2500 input features), a single split on
a pixel would be possible to see in 1D however it would not come close to telling the
entire classifier story. Instead, a method of presenting the classifier was developed for
this work by the author.
Since only one pixel is used at a time in the input feature vectors, they can be
traced back to a specific location in the image. Therefore, at the end of training a
collection of features (pixels) used in classification can be counted and sorted. From
this compiled list, the frequency a specific pixel was used in the classifier is mapped
back to the original spectral image. Finally, an entire 50x50 image is generated to
represent what the classifier "sees" as the most important features or pixels in a
training image. It is beneficial to view these images in two modes, binary and scaled.
The binary images simply shows what pixels were used in training. No matter the
pixel’s frequency, if it was used a value of 1 is assigned, and if not a value of 0.
This representation helps to show how focused the classifier was during training. For
example, if there is a large spread of pixels it might have struggled to find key features.
Also, the binary image helps to show the lower frequency pixels that are often hidden
in the second representation. This alternate visual is a scaled image. Here, a pixel is
directly assigned its frequency used in the classifier. Then, when showing the image
it is done in full color scale. The scaled image helps show the specific pixels the
classifier gravitated towards to make decisions. Even more so than the binary image,
the scaled pixels clearly show the most important features and regions the classifier
chose to focus on. Figure 5-5 shows an example of both the binary (left) and scaled
(right) classification visualizations.
5.3 Experimental Results
Once the experimental data was collected, processed, and used to train each specific
classifier the final testing results could be determined. The following tables outline the
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Figure 5-5: Weak Learner Visualization
test set accuracy and confusion matrix for each specific training/testing case. Splits
between aortic, LVAD, inlet, and outlet cases were made for readability of Tales 5.7,
5.8, 5.9, and 5.10.
Table 5.7: Aortic Site Outlet Occlusion








allao 1200/640 93.29% 209 29 236 3
allao (var) 1200/240 71.30% 106 8 58 58
T50ao 400/160 93.75% 79 1 71 9
T60ao 400/160 100.00% 80 0 80 0
T70ao 400/160 91.72% 66 12 78 1
LOO50ao 800/80 91.88% 67 13 80 0
LOO60ao 800/80 85.00% 60 20 76 4
LOO70ao 800/80 53.50% 74 4 10 69
Table 5.8: Aortic Site Inlet Occlusion








allai 1200/640 52.84% 50 188 201 36
T50ai 400/160 45.28% 66 14 6 73
T60ai 400/160 50.63% 11 69 70 10
T70ai 400/160 53.85% 20 58 64 14
LOO50ai 800/80 59.75% 50 30 65 14
LOO60ai 800/80 61.88% 36 44 63 17
LOO70ai 800/80 50.00% 4 74 74 4
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Table 5.9: LVAD Site Outlet Occlusion








allvo 1200/640 50.31 % 240 0 0 237
T50vo 400/160 51.24 % 83 0 0 79
T60vo 400/162 50.63 % 81 0 0 79
T70vo 400/160 49.03 % 76 0 0 79
LOO50vo 800/80 51.24 % 83 0 0 79
LOO60vo 800/80 50.63 % 81 0 0 79
LOO70vo 800/80 53.55 % 73 3 10 69
Table 5.10: LVAD Site Inlet Occlusion








allvi 1200/640 68.05 % 156 84 172 70
T50vi 400/160 00.03 % 1 82 4 77
T60vi 400/162 100.00% 81 0 81 0
T70vi 400/160 96.15 % 71 5 79 1
LOO50vi 800/80 100.00% 83 0 81 0
LOO60vi 800/80 76.54 % 49 32 75 6




This chapter will draw conclusions from the previous experimental results, propose
explanations for the given results, and propose future improvements to this work,
6.1 Classification Accuracy
As seen in Tables 5.7,5.8, 5.9, and 5.10 the classification accuracy achieved widely
varied depending on the measurement site and blockage configuration. As expected,
the greatest accuracy came with measuring directly above an aortic blockage. The
reason for this high accuracy is twofold. First, the measurement was taken directly
above the blockage. Disregarding any system effects, one is always to expect bet-
ter results when taking a measurement closer to the fault. There is less chance of
outside factors clouding the signal such as tube compliance or ambient noise. The
second factor that may have contributed to the "ao" classifiers’ success was the outlet
blockage’s effect on ventricular flow.
During healthy operation of both the cardiac phantom and most LVAD patients,
ventricular flow is primarily dominated by the LVAD path. The 𝛿𝑃 created by the
pump between the left ventricle and aorta outweighs that of the ventricle alone. This
heightened aortic back pressure combined with a weakened ventricular wall often
leads to the aortic value remaining closed during typical cardiac function [18]. Here,
the LVAD is functioning in series with the overall cardiac circuit. When the LVAD
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is in a faulted state, the 𝛿𝑃 may no longer be high enough to overcome the chamber
pressure provided by the heart itself. Then, the aortic value opens and the LVAD
and ventricle function in parallel. Similar to a patient, this behavior was seen in the
cardiac simulator with the outlet blockage installed. The two flow paths (LVAD and
ventricle) meeting is proposed to be the main feature the "ao" classifiers learned.
Evidence for this claim comes from the classier visualizations outlined in Chapter
5. Here, it is clear that the weak learners gravitate to the S1 region. In the time
domain, this area could likely be the ventricular flow reaching the aorta after the
systole phase is initiated. This feature also addresses the concern that the classifier
is simply detecting a lower flow rate in the faulted samples. Being able to detect low
flow would not be a flaw in the system, however it is the goal of this work to detect
more complex flow changes. For example, instead of detecting lower LVAD flow the
classifier may pick up on a shift in the S1.
Although the aortic outflow classifier obtained favorable results, this was not the
case in the remaining locations. Unfortunately, the "ai","vi", and "vo" cases all did
not perform consistently on their respective test sets. Even though a few classifiers
did achieve very a high accuracy, when viewing the weak learners it was clear these
results were not valid. For example, T60vi achieved 100% test set accuracy as shown
by Table 5.10. However as T60viVIZ shows, the weak learners (pixels) used are all
centered around the bottom of the image in a small cluster. This tightly packed
region suggests that by chance all the images derived from experimental testing had
a slight difference in spectral intensity at this location. Furthermore, this extremely
high accuracy was not shared with the other BPM cases. Therefore, the "vi" classifier
is deemed unsuccessful. As for the "ai" classifier, it may have not achieved similar
accuracy as the "ao" but it was much more consistent than the LVAD measured cases.
A key reason for the inconsistent classifier performance on LVAD measurement
data may be the significant acoustic presence of the LVAD. Measuring at this location
through the EcoFlex picked up on a great deal of vibrations from the LVAD, making
it difficult to detect any other flow characteristics. Figure 6-1 clearly shows this
phenomena, showcasing healthy and faulted images from both "ao" and "vi" cases.
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In the top images (aortic), there is a clear distinction near the S1 area of the image.
However, the bottom images (LVAD) do not show any clear differences.
Figure 6-1: Evidence of LVAD spectral dominance compared to aortic measurements
This claim is further supported by the classifier visualizations for these two cases.
As shown in Fig. 6-2, the aortic measurement case focuses in on the S1 region and
places significant weak learners in that area. Alternatively, the LVAD classifier cannot
decern any conrete features and the weak learners are widely spread across the 50x50
image.
Another important conclusion to draw from this work is the performance on vari-
able heart rate data. The variable case did not match that of the consistent heart
rate, however it was consistent with the average "leave one out" performance. In the
future, it may be worth training and testing with variable as opposed to fixed heart
rates. This would better mimic future patient data and drastically reduce the amount
of classifiers allow for more efficient data collection.
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Figure 6-2: Classifier visualizations comparison between aortic and LVAD measure-
ment locations
Finally, it is important to compare the previous support vector machine (SVM)
to the presented classification tree. The primary comparison between the two comes
from the features used. As mentioned in Chapter 4, the CT does not used any
manually extracted features or regions of interest opposed to the SVM which used
both. In practice, eliminating these manual features streamlines the image processing
step and results in a robust classifier. This is evident by the "ao" classifiers which
learned features which lead to classification of heart rate data never seen during
training. The previous SVM struggled with these cases as the region of interest often
needed to be translated in time to capture defining spectral features. However, using
manually selected regions of interest does have its advantages. First, the training
process is more simple and requires less training data (SVM vs. CT). Also, the
image can be cropped into regions of interest at a higher resolution, maintaining
smaller features than with the down-sampled 50x50 representation. Overall, the two
classifiers both performed well on their respective data sets and cardiac simulators
(original vs. revised). A direct accuracy comparison is not just in this case as the goal
of this work was to explore a new classifier for time-frequency spectra classification,
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not to overshadow the previous work completed by Prechtl et al. [37].
6.2 Future Considerations
Upon completion of this work, key components of the thrombus classification process
may be improved in future iterations. The first of which is the way training/testing
are carried out with collected experimental data. Using the in vitro cardiac simulator,
it is quite simple to change the physiology of the "patient". This is not the case in a
clinical setting. Therefore, the multiple of cases and data sets obtained in this work
may not be possible to collect for each patient. This may motivate a shift away from
traditional "healthy" vs. "faulted" classification and more towards nuance detection
methods. In addition, the classification algorithm may need to be changed from the
proposed boosted classification tree.
Another improvement to the project would be an in depth investigation on filtering
the LVAD audio signal. Especially in the "vi" cases, the LVAD frequency band
dominated the spectral images. This was disadvantageous to classification as the
LVAD band was so chaotic that no definitive features were able to be extracted.
Therefore, the pronounced region overshadowed the remaining frequency features
and lead to inconsistent classifier performance. In the future, it would be worth
designing a filter to diminish or remove the LVAD frequency components prior to the
CWT. Filter design was out of the scope of this work due to the additional validation
needed to make sure no core frequency components would be effected. Figure 6.2
below shows a potential filter applied to one of the LVAD spectral images. It is clear
that the LVAD band is less pronounced relative to lower frequency components in
the filtered image. However, it is not clear that the filter does not alter non-LVAD
regions of the spectra.
Overall, this work accomplishes the goals set forth in the proposal. The primary
of those being,
 Incorporate inlet occlusions
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Figure 6-3: Effect of filtering on sample LVAD spectral image
 Revise outlet occlusion
 Develop new heart rate controller for cardiac simulator
 Develop image based classifier for time-frequency spectra
 Revise original cardiac simulator
In addition, secondary objectives such as variable heart rate testing and the de-
velopment of a digital ECG stethoscope were included in this work. Although the
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